COVID-19: Diagnosis and Management-Part II

The Future of COVID-19 Treatment

Author(s): Sahil Arora, Manvendra Kumar, Gaurav Joshi* and Raj Kumar *

Pp: 169-200 (32)

DOI: 10.2174/9781681088051121010009

* (Excluding Mailing and Handling)


Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) or coronavirus disease or COVID-19 is a disease that has led to colossal mortality worldwide. The fast spread of this disease has caused havoc and panic among individuals, which has further worsened with the unavailability of vaccines or some proven drug regime. To date, only 12 new antiviral drugs have been approved by the FDA (8 against hepatitis C virus (2 in combinations for HIV). Thus, it becomes of utmost importance to identify drugs for new and re-emerging viruses, including the coronavirus. Considering the quest, we have put forth this book chapter to update readers about current repurposed and experimental drugs for this novel coronavirus. The viral lifecycle assisted in providing vital potential targets for drug therapy. The present chapter also deals with the existing mechanism of action of the drugs, their category, and clinical data reported.

Keywords: ACE2 inhibitors, Antiarrhythmic, Antibacterial, Anticancer, Anticoagulants, Antidiabetic, Antifungal, Anti-inflammatory, Antimalarial, Antioxidant, Antiparasitic, Antiprotozoal, Antiviral, Chelating agents, COVID- 19, Drug repurposing, Natural products, Psychotropics, RAAS-ACE-ARBs inhibitors, SARS-CoV-2.

Related Journals
Related Books
© 2024 Bentham Science Publishers | Privacy Policy